CTRI/2023/03/050979
Completed
未知
To evaluate Ophthalmological safety of test product involving subjects of normal eye conditions & contact lens user on healthy female subjects
DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED0 sites33 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Indian Female subjects.
- •2\)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
- •3\)Between 18 and 40 years of age.
- •4\)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
- •5\)Subjects having normal eye conditions \& contact lens user, having habit of using face wash.
Exclusion Criteria
- •1Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
- •2Having refused to give her assent by not signing the consent form.
- •3Taking part in another study liable to interfere with this study.
- •4Being insulin\-dependent diabetic or non insulin\-dependent diabetic with a recent therapy (less than 6 months).
- •5Having a progressive asthma (either under treatment or last fit in the last 2 years)
- •6Being epileptic.
- •7Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months).
- •8Having cutaneous hypersensitivity.
- •9Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •10Following a chronic medicinal treatment comprising any of the following products: aspirin\-based products, anti\-inflammatories, anti\-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of eye safety of test productCTRI/2022/07/043782ONESTO LABS PVT LTD
Not yet recruiting
Not Applicable
Assessment of Ophthalmological safety of skin care productCTRI/2023/11/059530DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED
Completed
Not Applicable
To test the safety of hydration mist on eyes during usage.CTRI/2023/05/053058DPKA Universal Consumer Ventures Private Limited33
Completed
Phase 4
To evaluate the safety of Primary Irritation Patch Test test product in healthy volunteersCTRI/2022/12/048219Vasu Health Care24
Completed
Phase 4
Safety evaluation of test products on healthy skin typeCTRI/2023/03/050796Dabur India Limited24